This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Roche Glycart Ag. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Sandra Grau - Innovator in Bispecific Antibodies
Introduction
Sandra Grau is a prominent inventor based in Birmensdorf, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. Her work focuses on innovative solutions that have the potential to impact therapeutic applications.
Latest Patents
Sandra holds a patent for her invention titled "DR5—FAP bispecific death receptor agonistic antibodies." This invention relates to bispecific antibodies that comprise a first antigen binding site specific for a death receptor and a second antigen binding site specific for a second antigen. The patent also covers methods for their production, pharmaceutical compositions containing these antibodies, and their various uses. She has 1 patent to her name.
Career Highlights
Sandra is currently employed at Roche Glycart AG, a leading company in the field of biopharmaceuticals. Her role involves research and development of innovative therapeutic solutions that leverage her expertise in antibody technology.
Collaborations
Throughout her career, Sandra has collaborated with notable colleagues, including Peter Bruenker and Claudia Ferrara Koller. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Sandra Grau is a key figure in the development of bispecific antibodies, with her patent showcasing her innovative contributions to biotechnology. Her work at Roche Glycart AG and collaborations with esteemed colleagues further highlight her impact in the field.